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Abstract 30 
Accurate identification of mastitis-causing bacteria supports effective 31 
management and can be used to implement selective use of antimicrobials for 32 
treatment. The objectives of this study were to compare the results from a culture-33 
based mastitis pathogen detection test kit (‘VetoRapid’, Vétoquinol) with standard 34 
laboratory culture and to evaluate the potential suitability of the test kit to inform a 35 
selective treatment programme. Overall 231 quarter milk samples from five UK dairy 36 
farms were collected. The sensitivity and specificity of the test kit for the 37 
identification of Escherichia coli, Staphylococcus aureus, coagulase-negative 38 
staphylococci, Streptococcus uberis and Enterococcus spp., ranged from 17% to 84% 39 
and 92% to 98% respectively. Twenty-three of 68 clinical samples were assigned as 40 
meeting the requirement for antimicrobial treatment (Gram-positive organism 41 
cultured) according to standard culture results, with the test kit results having 42 
sensitivity and specificity of 91% and 78% respectively. Several occurrences of 43 
misidentification are reported, including Staphylococcus aureus being misidentified as 44 
coagulase-negative staphylococci and vice-versa. The test kit provides rapid 45 
preliminary identification of five common causes of bovine mastitis under UK field 46 
conditions and is likely to be suitable for informing selective treatment of clinical 47 
mastitis caused by Gram-positive organisms.  48 
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Introduction 49 
Intra-mammary infection (IMI), or mastitis, is estimated to be the most 50 
expensive disease in the dairy industry and is the most frequent reason for 51 
antimicrobial use (Mitchell and others 1998; More and others 2010). In a US study, 52 
80% of all antimicrobial drugs administered to dairy cattle were used for treatment or 53 
prevention of mastitis (Pol and Ruegg 2007). Effective control of mastitis can reduce 54 
problems attributed to the extensive use of antimicrobials in food animals such as 55 
antimicrobial residues and the potential for antimicrobial resistance (Erskine and 56 
others 2003; Makovec and Ruegg 2003; Pol and Ruegg 2007; UK-government 2013).  57 
Identification of mastitis-causing organisms on individual farms has been a 58 
key component of prevention planning for many years (Ruegg 2003). Once the 59 
causative agents of clinical and sub-clinical cases are established at the herd level, 60 
control measures can be targeted to reduce the source and spread of bacteria. A more 61 
recent development has been the use of pathogen identification to inform individual 62 
cow treatment protocols for clinical mastitis during lactation, with the potential to 63 
further reduce antimicrobial use (Cameron and others 2013; Lago and others 2011a). 64 
Several authors have reported that mild and moderate clinical mastitis cases caused by 65 
E. coli species do not benefit from antimicrobial therapy (Roberson 2012; Suojala and 66 
others 2013). 67 
Targeted treatment requires rapid and accurate pathogen identification tests. 68 
Standard laboratory culture and modern molecular diagnostics are the preferred 69 
methods, but they cannot be performed outside of professional laboratories. The delay 70 
associated with submitting samples to a laboratory means that there is normally more 71 
than a 24 hour delay between detecting the mastitis and receiving the result, making 72 
them difficult to use in targeted treatment protocols currently. The limited number of 73 
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pathogen species associated with most mastitis cases (Bradley and others 2007; 74 
Koivula and others 2007; Makovec and Ruegg 2003; Tenhagen and others 2006; 75 
Watts and Yancey 1994) facilitates the design of simplified culture-based detection 76 
kits, where a single milk sample can be cultured concurrently on selective multiple 77 
media plates. With appropriate interpretative guides, these kits allow crude, culture-78 
based differentiation of major pathogen groups to be performed by a suitably trained 79 
person (non-microbiologist), with preliminary results available within 18-24 hours of 80 
sampling. 81 
A recent US trial that used selective treatment protocols for clinical mastitis 82 
demonstrated no difference in cure rate, recurrence rate or long term production 83 
output when withholding antimicrobial treatment from cases where Gram-negative 84 
bacteria, no bacteria or yeasts were cultured using an ‘on-farm’ test kit (Lago and 85 
others 2011a, b). The proportion of such clinical cases will vary depending on the 86 
farm. Reduced antimicrobial use has also been reported from US farms using on-farm 87 
pathogen culture kits at the end of lactation (on cows with low somatic cell counts) to 88 
help decide whether to administer antimicrobials at dry off (Cameron and others 89 
2013). 90 
In Europe, it remains common practice to treat all cases of clinical mastitis 91 
with antimicrobial therapy, despite culture-based pathogen identification kits being 92 
available. To our knowledge, there are no reports in the literature comparing such kits 93 
to standard laboratory culture for pathogen identification in samples from UK dairy 94 
herds. The aim of this study was to compare the results from a culture-based mastitis 95 
pathogen detection test kit (‘VetoRapid’, Vétoquinol), with standard laboratory culture 96 
using milk samples collected from commercial UK dairy farms, and to evaluate the 97 
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suitability of the test kit to inform a selective treatment programme for clinical 98 
mastitis. 99 
 100 
Materials and methods 101 
Farm and animal selection 102 
Samples were collected between May 2012 and January 2013 from five herds 103 
located in Scotland (Table 1). Three herds (1, 2 and 3), were enrolled in a year-round 104 
routine monitoring service provided by the Scottish Centre for Production Animal 105 
Health and Food Safety (SCPAHFS, School of Veterinary Medicine, University of 106 
Glasgow) with weekly visits. The remaining herds (4 and 5) were visited once by 107 
SCPAHFS veterinary surgeons to conduct an individual herd mastitis investigation. 108 
Background information from the five farms is shown in Table 1. 109 
Quarters with clinical and sub-clinical bacterial infections were identified for 110 
sampling. Clinical mastitis was detected if a quarter was swollen and / or painful, or if 111 
there were physical changes in the milk (flakes, clots or a watery appearance). Sub-112 
clinical mastitis was detected when the cow had a SCC greater than 200,000 cells/mL 113 
at the most recent milk recording of cow milk (composite of all milking quarters). On 114 
those animals, a California Mastitis Test (CMT) was carried out to detect the affected 115 
quarter(s) for sampling (Deb and others 2013).  116 
 117 
Sample collection 118 
Milk samples were collected aseptically by a single veterinary surgeon from 119 
the SCPAHFS (LV) or by an individual, trained member of the on-farm staff, 120 
following guidelines recommended by the National Mastitis Council (2004). Briefly, 121 
these require wearing disposable gloves, thoroughly washing and drying the teat, 122 
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discarding several streams of milk, dipping and wiping the teat with a pre-milking teat 123 
disinfectant, scrubbing the teat end with cotton soaked in 70% alcohol, collection of 124 
two or more streams of milk into a sterile container, and securing the cap 125 
immediately. 126 
After collection, samples were moved within four hours to -20oC storage 127 
either at the University of Glasgow or temporarily to an on-farm freezer until transfer 128 
while frozen to the University of Glasgow (National Mastitis Council 2004). All 129 
samples were cultured within four weeks. 130 
 131 
Microbiological analysis 132 
Milk samples were removed from the freezer and allowed to reach room 133 
temperature before being agitated for five seconds. Samples were processed 134 
concurrently by a laboratory technician in the Infectious Diseases Diagnostic Unit, 135 
Veterinary Diagnostic Services, School of Veterinary Medicine, University of 136 
Glasgow (IDU) using standard laboratory methods, and by LV using the test kit. 137 
 138 
Standard laboratory culture (standard culture) 139 
The samples were processed by standard laboratory methods for the 140 
microbiological analysis of milk (National Mastitis Council 1999). Briefly, a sterile 141 
cotton swab was saturated with the milk, and lawn cultures were prepared in the 142 
corners of MacConkey and 5% sheep blood agar plates (E & O Laboratories) before 143 
streaking with a sterile loop. The plates were incubated aerobically at 37oC for 24-48 144 
hours before being read. All organisms were identified by standard laboratory 145 
methods (including colony morphology, Gram stain, pattern of haemolysis and 146 
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biochemical profile). An appropriate API test (bioMérieux) was performed for 147 
speciation when required (National Mastitis Council 1999). 148 
 149 
Culture-based pathogen detection test kit  150 
Samples were plated concurrently onto the test kit. The  test kit comprises a 151 
single plate containing three distinct sectors of selective medium: a customised agar 152 
targeting coliforms that contains bile salts and vancomycin that inhibit the growth of 153 
Gram-positive bacteria (sector 1; proprietary); a modified mannitol-salt agar (MSA) 154 
which supports the growth of organisms that tolerate high salt concentrations such as 155 
Staphylococcus spp., and can aid the differentiation of mannitol fermenters such as S. 156 
aureus from non-mannitol fermenters such as the coagulase-negative staphylococci 157 
(CNS) (sector 2; proprietary); and a modified Edwards agar that contains 158 
antimicrobials crystal violet and Polymyxin B that inhibit the growth of staphylococci 159 
and Gram-negative bacteria respectively (sector 3; proprietary).  160 
The test kit was prepared and read by a single farm animal clinician from the 161 
SCPAHFS (LV) according to the manufacturer’s instructions, but without any specific 162 
training or experience in microbiological techniques. A sterile cotton swab was 163 
saturated with the milk and a lawn culture was prepared in the corner of each sector 164 
before streaking with a sterile loop. The test kits were incubated aerobically at 37oC 165 
for 24-48 hours. 166 
Utilising the accompanying interpretative guidelines, a crude identification of 167 
eight of the most common mastitis-causing bacteria or bacterial groups was made as 168 
follows: E. coli (dark blue colonies growing on sector 1), Klebsiella spp. (red-purple 169 
colonies growing on sector 1), S. aureus (yellow, golden colonies and agar on sector 170 
2), CNS (clear colonies and no change in the agar colour on sector 2), S. uberis (black 171 
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colonies and agar on sector 3), Enterococcus spp. (black colonies and agar on sector 3 172 
together with pinhead yellow colonies and discoloration of sector 2), S. dysgalactiae 173 
(clear colonies on sector 3 with green coloured corona at 48 hours and red-brown agar 174 
coloration) or S. agalactiae (clear colonies on sector 3 with clear-bright corona at 48 175 
hours and red-brown agar coloration). All organisms growing on the test kit were 176 
classified into one of these 8 groups.  177 
 178 
Initial data analysis 179 
The results from standard culture were considered definitive. Data were stored 180 
and analysed using Microsoft Excel 2007. Sensitivity and specificity (+/- 95% 181 
Confidence Interval (using the formula: x̅ ± 1.96 * σ/√(n), where x̅ represents the 182 
mean, σ the standard deviation, and n the sample size) of the test kit compared to 183 
standard culture were calculated. To estimate positive predictive values and negative 184 
predictive values, the proportion of organisms of the appropriate type identified in all 185 
samples was taken as prevalence. 186 
 187 
Use of the  test kit for selective treatment 188 
Two hypothetical treatments (antimicrobial treatment or no antimicrobial 189 
treatment) were assigned to each clinical sample based on results from standard 190 
culture and the test kit using the model described by Lago and others (2011a). Based 191 
on this model, antimicrobials are assigned only when a Gram-positive organism is 192 
isolated. The suitability of the resultant treatment choices were compared, with the 193 
sensitivity (95% Confidence Interval), specificity (95% Confidence Interval), positive 194 
predictive values and negative predictive values calculated for the test kit compared to 195 
standard culture. 196 
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 197 
Qualification of incorrectly identified pathogens 198 
Two methods were used to investigate the potential for misidentification of 199 
pathogens by the test kit. First, a subset of results was created where, for a given 200 
sample, a pathogen was isolated in pure culture by both standard culture and the test 201 
kit but where there was disagreement on the identity of the pathogen. In these cases 202 
standard culture was assumed to have correctly identified the only organism present, 203 
and the test kit assumed to have misidentified the organism. 204 
In addition, nine mastitis isolates previously identified by the IDU laboratory 205 
as E. coli, Klebsiella spp., S. aureus, Staphylococcus epidermidis, S. uberis, 206 
Enterococcus faecalis (E. faecalis), Aerococcus viridians (A. viridans), S. 207 
dysgalactiae and S. agalactiae were obtained from storage at the IDU and cultured in 208 
parallel using standard culture and the test kit by an IDU laboratory technician. 209 
Aerococcus viridans was included because of its morphological and biochemical 210 
similarity to E. faecalis. The IDU laboratory technician read all plates after 24-48 211 
hours and compared the results to the original, known isolate. 212 
 213 
Results 214 
Microbiological Analysis 215 
A total of 231 samples were included in the study. Sixty-eight were collected 216 
from clinical cases and 163 from subclinical cases (Table 1). 217 
Of all standard culture results, no bacteria were recovered from 98 samples 218 
(42.4%), a pure bacterial culture was recovered from 116 samples (50.2%), and two 219 
different organisms were recovered from 17 samples (7.4%). No samples had three or 220 
more bacteria isolated. 221 
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A total of 150 individual organisms were isolated by standard culture from 222 
133 samples, of which 46 (31%) could not be identified by the test kit as they were 223 
not one of the eight identifiable groups (25 Bacillus spp., 10 A. viridans, 3 224 
unidentified Gram-positive rods, 3 yeast organisms, 2 Serratia spp., 1 Lactococcus 225 
lactis, 1 Proteus sp., 1 Pseudomonas sp.). 226 
The most common bacterial group isolated was CNS (19% of all pathogens). 227 
Bacillus spp. (single or sparse colonies) was isolated as the only organism in 17 228 
samples (six from farm 1, seven from farm 2 and four from farm 4) and in eight 229 
samples together with another organism (twice with E. coli and CNS, and once each 230 
with S. aureus, Enterococcus spp., Lactococcus lactis and Pseudomonas sp.).   231 
There were very few isolates of S. dysgalactiae (5 isolates), S. agalactiae (1 232 
isolate) and Klebsiella spp. (never isolated) in the final data-set and no test 233 
characteristics were estimated for these pathogens. The sensitivity, specificity, 234 
positive predictive values and negative predictive values of the five other pathogens 235 
(E. coli, S. aureus, CNS, S. uberis, Enterococcus spp.) are shown in Table 2. 236 
 237 
Use of the  plate for selective treatment 238 
Twenty-three of the 68 clinical samples were assigned as meeting the 239 
requirement for antimicrobial treatment according to the protocol described by Lago 240 
and others (2011a). The comparison of assignment of antimicrobials based on 241 
standard culture and the test kit results are shown in Table 3. 242 
 243 
Qualification of incorrectly identified pathogens 244 
Twenty-four samples were identified where a pathogen was isolated in pure 245 
culture by both standard culture and the test kit but with disagreement on pathogen 246 
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identity. CNS was incorrectly identified as S. aureus in four samples and S. aureus 247 
was incorrectly identified as CNS in two samples. Enterococcus spp. was incorrectly 248 
identified as S. uberis in two samples, Bacillus spp. was incorrectly identified as 249 
Enterococcus spp. in three samples and A. viridans was incorrectly identified as S. 250 
uberis in two samples. The remaining 11 misidentifications occurred only once each 251 
(E. coli, S. agalactiae and Bacillus spp. were each misidentified as S. uberis; CNS, S. 252 
aureus, S. uberis, S. dysgalactiae and A. viridians were each misidentified as 253 
Enterococcus spp; Enterococcus spp. and Bacillus spp. were each misidentified as 254 
CNS; and A. viridians was misidentified as S. aureus). 255 
All nine stored mastitis isolates were correctly identified by standard culture 256 
on repeat culture. The test kit correctly identified E. coli, Klebsiella, S. agalactiae and 257 
S. dysgalactiae isolates. S. aureus was incorrectly identified as CNS (Figure 1), and S. 258 
epidermidis was incorrectly identified as S. aureus. Both S. uberis and A. viridans 259 
were incorrectly identified as E. faecalis. 260 
 261 
Discussion 262 
The first aim of this study was to compare the results from the test kit with 263 
standard culture using milk samples collected from commercial UK dairy farms. The 264 
size of the dataset was limited and the results for only five of the eight pathogens 265 
identifiable by the test kit are reported. For each of the five pathogen species assessed, 266 
the individual specificity of the test kit is above 90%. The low prevalence of each 267 
individual pathogen in this study has allowed the accurate estimate of these specificity 268 
values, reflected in the narrow confidence intervals reported. The sensitivity reported 269 
for the five pathogens assessed is much more variable (17-84%) with wider 270 
confidence intervals reflecting the low numbers of positive samples in the dataset. The 271 
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mean sensitivity estimate of the test kit was higher for all pathogens in clinical 272 
samples compared to sub-clinical samples (with the exception of Enterococcus spp. 273 
which was never isolated from a clinical sample). This may be due to a higher number 274 
of bacteria being present in these samples, increasing the likelihood of growth on 275 
selective media (Persson and others 2011). The results reported here may therefore be 276 
an under-estimate of the kit’s performance if only used on clinical samples, and an 277 
over-estimate of the kit’s performance if only used on sub-clinical samples. The 278 
accuracy of test characteristic estimates could have been improved by expanding the 279 
dataset to increase the number of positive samples. 280 
The second aim of the study was to evaluate the suitability of using the  test kit 281 
to implement a selective antimicrobial treatment regimen described previously (Lago 282 
and others 2011a), in which antimicrobial therapy is only used when Gram-positive 283 
bacteria are isolated. The test kit was found to be reasonably sensitive for identifying 284 
Gram-positive organisms from clinical cases, though the specificity is lower. This 285 
suggests that it would be possible to use the test kit to reduce antimicrobial therapy 286 
(compared to non-selective treatment) without significant risk of missing cases where 287 
Gram-positive bacteria are present. Further work is required to determine whether 288 
short and long-term outcomes (including cure rate, recurrence rate and milk yield) 289 
would be affected in cows from which antimicrobials were withheld following 290 
implementation of such a protocol under UK field conditions. 291 
Results from the test kit were compared to results from standard laboratory 292 
culture. Pathogen identification by both of these methods relies on phenotypic 293 
characteristics that are known to occur frequently in the particular pathogen group or 294 
species. Identification by standard laboratory culture is likely to be more accurate as it 295 
considers many more phenotypic and biochemical characteristics than the test kit.  296 
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However, results from standard culture are known to be imperfect and subject to inter-297 
laboratory variation (Pitkälä and others 2005). Modern molecular techniques can 298 
improve sensitivity and reduce identification errors that result from phenotypic 299 
variation within species (Bautista-Trujillo and others 2013; Becker and others 2004; 300 
Keane and others 2013). This study could have been improved by identifying all 301 
isolates (from laboratory culture and test kits) by molecular methods, though this was 302 
cost prohibitive. Comparison of ‘on-farm’ culture kits to standard laboratory culture is 303 
common in the recent scientific literature (Lago and others 2011a, b; Royster and 304 
others 2014), but the imperfect nature of organism identification by phenotypic traits, 305 
even in professional laboratories using standard methods, must always be considered 306 
when interpreting results. Several multiplex real-time PCR kits (that are not affected 307 
by phenotypic variation) are commercially available for mastitis pathogen 308 
identification, but they cannot yet be performed outside of professional laboratories, 309 
making them unsuitable for on-farm pathogen identification. 310 
The results reported here compare favourably to several previous reports of 311 
test characteristics for similar on-farm culture test kits using non-diluted, frozen 312 
clinical case samples. The sensitivity and specificity of the test kit for clinical cases 313 
caused by E. coli reported here (67% and 92% respectively) are similar to those 314 
reported for a different test kit in a Canadian study (71% and 89%, respectively) 315 
(Wallace and others 2011). Positive coliform results must always be interpreted 316 
carefully (particularly from sub-clinical samples where they are rarely isolated) as 317 
there is always a risk that the bacteria have originated from contamination of the 318 
sample rather than from a genuine IMI. The test characteristics of the  test kit for 319 
clinical cases caused by S. aureus (sensitivity: 83%, specificity: 94%) are also similar 320 
to those reported previously using an alternative test kit (sensitivity: 69.6%, 321 
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specificity: 96%) (Wallace and others 2011). The sensitivity and specificity of the test 322 
kit for identification of S. uberis reported here (84% and 92% respectively) are better 323 
than those reported for identifying streptococci using an alternative test kit 324 
(specificity: 54%, specificity: 22%) (Wallace and others 2011). To the authors’ 325 
knowledge, this is the first study that compares the results from a culture-based 326 
mastitis pathogen detection test kit with standard culture for CNS and Enterococcus 327 
spp. 328 
For two pathogens (S. agalactiae and S. dysgalactiae) there were few positive 329 
samples (1 and 5 respectively), and Klebsiella spp. was never isolated by standard 330 
culture during the study. Therefore, it was not possible to assess the performance of 331 
the test kit for these pathogens. Stored, frozen milk samples (in which the pathogen is 332 
already known) could have been used to assess the test kit, and therefore pre-333 
determine the number of each pathogen type assessed. However, this would not be 334 
representative of the prevalence on commercial UK farms, and would have introduced 335 
the risk of sample contamination during storage and handling and loss of viability of 336 
pathogens during long-term storage, making any results less reliable. Storing frozen 337 
milk samples for four weeks is unlikely to have any detrimental effect on pathogen 338 
viability, even without the use of preservative (Murdough and others 1996; Sol and 339 
others 2002). 340 
Previous studies comparing on-farm culture-based test kits with standard 341 
culture have reported that test characteristics can change depending on the experience 342 
of the operator (McCarron and others 2009; Royster and others 2014). This effect was 343 
not assessed in the current study. Pathogen identification using the test kit is 344 
subjective, and therefore the characteristics are likely to vary depending on the 345 
experience of the operator. 346 
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We reported six instances of misidentification between S. aureus and CNS in 347 
the subset of data where a single pathogen was isolated in pure culture by both 348 
standard culture and the test kit but with disagreement on pathogen identity. The two 349 
S. aureus cultures misidentified as CNS were presumptively identified by standard 350 
culture on the basis of their DNAse and haemolytic activity (2/2), and biochemical 351 
reactivity (1/1; ID32 Staph, BioMérieux). Four staphylococcal isolates misidentified 352 
as S. aureus were presumptively identified by standard culture as CNS due to their 353 
lack of haemolytic (3/4) and DNAse activity (4/4). DNAse enzyme activity correlates 354 
well with coagulase activity (Boerlin and others 2003), and is used as an alternative to 355 
coagulase testing in the IDU. The test kit differentiates S. aureus from CNS by 356 
recording MSA activity alone. However, this single phenotypic test may be unreliable 357 
in differentiating S. aureus from CNS since rare CNS strains are MSA-positive. 358 
Furthermore, S. aureus strains are not consistently haemolytic, and rare S. aureus 359 
strains can test negative for DNAse, coagulase or MSA activity (Akineden and others 360 
2011; Boerlin and others 2003; Kateete and others 2010). Such phenotypic variations 361 
may account for some of the discrepancies reported here. 362 
Two enterococcal isolates (E. faecalis and E. faecium, identified by the 363 
laboratory using API 20 Strep (bioMérieux) were mistakenly identified as S. uberis 364 
when using the test kit. Growth on MSA and colony size at 24 hours are the 365 
phenotypic traits used by the test kit but these are not consistent across strains. 366 
Standard culture can more readily distinguish enterococci based on their morphology, 367 
growth on MacConkey agar, and biochemical properties. Enterococci are rarely a 368 
primary cause of IMI and are often causes of sample contamination. 369 
A monoculture of Bacillus spp. was recovered from five milk samples using 370 
standard culture. Using the test kit, these five samples were reported as positive for 371 
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CNS (1), Enterococcus spp. (3) and S. uberis (1) monocultures. Given the pure 372 
cultures obtained, it is likely that Bacillus grew on Sectors 2 and 3 of the test kit. 373 
Bacillus spores are ubiquitous in the environment, and the few colonies recovered 374 
suggest that these are sample contaminants, stressing the importance of sterile sample 375 
collection technique if using the test kit system. 376 
A. viridans is a Gram-positive catalase-negative coccus, morphologically and 377 
biochemically similar to Enterococcus, but an infrequent mastitis pathogen only 378 
occasionally identified in routine diagnostics (Pitkala and others 2004). In this study, 379 
monocultures of A. viridans were recovered from four samples using standard culture. 380 
Since A. viridians grows on Sectors 2 and 3 of the test kit (data not shown), the 381 
organism was misidentified as S. aureus (1), S. uberis (2) and Enterococcus spp. (1). 382 
The significance of discrepant results depends on the decision made based on 383 
the result. For implementing a treatment programme as described above, identifying 384 
Gram-positive organisms as Gram-negative will lead to inappropriate withholding of 385 
antimicrobial therapy, though this occurred infrequently. In standard culture, routine 386 
Gram staining would eliminate this. Important management decisions (such as drying 387 
off a cow or quarter, or culling an animal from the herd) are often made when an 388 
animal is deemed to be chronically infected with contagious organisms that are 389 
difficult to treat, such as S. aureus. The results from this study suggest that standard 390 
culture (or a validated PCR test) remain the preferred pathogen identification tool for 391 
informing these decisions. Additional animal information (including SCC and clinical 392 
mastitis history, milk production, lactation number, etc.) should also always be 393 
considered in these cases. 394 
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In conclusion, use of the test kit is suitable for implementing targeted selective 395 
treatment of Gram-positive organisms in bovine mastitis under UK field conditions. 396 
The test reliability varies for each causative pathogen. 397 
 398 
Acknowledgments 399 
The authors would like to thank the SCPAHFS staff members for the support 400 
and time allowed in writing the manuscript. A special thanks to David Taylor for his 401 
time and advice on the article and to Vétoquinol UK Limited for providing the test 402 
kits and funding the laboratory tests.  403 
18 
 
References 404 
AKINEDEN, O., HASSAN, A. A., SCHNEIDER, E. &  USLEBER, E. (2011) A coagulase-negative 405 
variant of Staphylococcus aureus from bovine mastitis milk. J Dairy Res 78, 38-42 406 
BAUTISTA-TRUJILLO, G. U., SOLORIO-RIVERA, J. L., RENTERIA-SOLORZANO, I., 407 
CARRANZA-GERMAN, S. I., BUSTOS-MARTINEZ, J. A., ARTEAGA-GARIBAY, R. I., 408 
BAIZABAL-AGUIRRE, V. M., CAJERO-JUAREZ, M., BRAVO-PATINO, A. &  VALDEZ-409 
ALARCON, J. J. (2013) Performance of culture media for the isolation and identification of 410 
Staphylococcus aureus from bovine mastitis. J Med Microbiol 62, 369-376 411 
BECKER, K., HARMSEN, D., MELLMANN, A., MEIER, C., SCHUMANN, P., PETERS, G. &  412 
VON EIFF, C. (2004) Development and evaluation of a quality-controlled ribosomal sequence 413 
database for 16S ribosomal DNA-based identification of Staphylococcus species. J Clin Microbiol 42, 414 
4988-4995 415 
BOERLIN, P., KUHNERT, P., HUSSY, D. &  SCHAELLIBAUM, M. (2003) Methods for 416 
identification of Staphylococcus aureus isolates in cases of bovine mastitis. J Clin Microbiol 41, 767-417 
771 418 
BRADLEY, A. J., LEACH, K. A., BREEN, J. E., GREEN, L. E. &  GREEN, M. J. (2007) Survey of 419 
the incidence and aetiology of mastitis on dairy farms in England and Wales. Veterinary Record 160, 420 
253-258 421 
CAMERON, M., KEEFE, G. P., ROY, J. P., DOHOO, I. R., MACDONALD, K. A. &  MCKENNA, S. 422 
L. (2013) Evaluation of a 3M Petrifilm on-farm culture system for the detection of intramammary 423 
infection at the end of lactation. Prev Vet Med 111, 1-9 424 
DEB, R., KUMAR, A., CHAKRABORTY, S., VERMA, A. K., TIWARI, R., DHAMA, K., SINGH, 425 
U. &  KUMAR, S. (2013) Trends in diagnosis and control of bovine mastitis: a review. Pak J Biol Sci 426 
16, 1653-1661 427 
ERSKINE, R. J., WAGNER, S. &  DEGRAVES, F. J. (2003) Mastitis therapy and pharmacology. 428 
Veterinary Clinics of North America Food Animal Practice 19, 109-138 429 
KATEETE, D., KIMANI, C., KATABAZI, F., OKENG, A., OKEE, M., NANTEZA, A., JOLOBA, M. 430 
&  NAJJUKA, F. (2010) Identification of Staphylococcus aureus: DNase and Mannitol salt agar 431 
improve the efficiency of the tube coagulase test. Annals of Clinical Microbiology and Antimicrobials 432 
9, 23 433 
KEANE, O. M., BUDD, K. E., FLYNN, J. &  MCCOY, F. (2013) Increased detection of mastitis 434 
pathogens by real-time PCR compared to bacterial culture. Vet Rec 173, 23 435 
KOIVULA, M., PITKÄLÄ, A., PYÖRÄLÄ, S. &  MÄNTYSAARI, E. A. (2007) Distribution of 436 
bacteria and seasonal and regional effects in a new database for mastitis pathogens in Finland. Acta 437 
Agriculturae Scandinavica, Section A – Animal Science 57, 89-96 438 
LAGO, A., GODDEN, S. M., BEY, R., RUEGG, P. L. &  LESLIE, K. (2011a) The selective treatment 439 
of clinical mastitis based on on-farm culture results: I. Effects on antibiotic use, milk withholding time, 440 
and short-term clinical and bacteriological outcomes. Journal of Dairy Science 94, 4441-4456 441 
LAGO, A., GODDEN, S. M., BEY, R., RUEGG, P. L. &  LESLIE, K. (2011b) The selective treatment 442 
of clinical mastitis based on on-farm culture results: II. Effects on lactation performance, including 443 
clinical mastitis recurrence, somatic cell count, milk production, and cow survival. Journal of Dairy 444 
Science 94, 4457-4467 445 
MAKOVEC, J. A. &  RUEGG, P. L. (2003) Results of Milk Samples Submitted for Microbiological 446 
Examination in Wisconsin from 1994 to 2001. Journal of Dairy Science 86, 3466-3472 447 
MCCARRON, J. L., KEEFE, G. P., MCKENNA, S. L., DOHOO, I. R. &  POOLE, D. E. (2009) 448 
Evaluation of the University of Minnesota Tri-plate and 3M Petrifilm for the isolation of 449 
Staphylococcus aureus and Streptococcus species from clinically mastitic milk samples. Journal of 450 
Dairy Science 92, 5326-5333 451 
MITCHELL, J. M., GRIFFITHS, M. W., MCEWEN, S. A., MCNAB, W. B. &  YEE, A. J. (1998) 452 
Antimicrobial drug residues in milk and meat: causes, concerns, prevalence, regulations, tests, and test 453 
performance. Journal of Food Protection 61, 742-756 454 
MORE, S. J., MCKENZIE, K., O’FLAHERTY, J., DOHERTY, M. L., CROMIE, A. R. &  MAGAN, 455 
M. J. (2010) Setting priorities for non-regulatory animal health in Ireland: Results from an expert 456 
Policy Delphi study and a farmer priority identification survey. Preventive Veterinary Medicine 95, 457 
198-207 458 
MURDOUGH, P. A., DEITZ, K. E. &  PANKEY, J. W. (1996) Effects of Freezing on the Viability of 459 
Nine Pathogens from Quarters with Subclinical Mastitis. Journal of Dairy Science 79, 334-336 460 
NATIONAL MASTITIS COUNCIL (1999) Laboratory handbook on bovine mastitis, National Mastitis 461 
Council 462 
19 
 
NATIONAL MASTITIS COUNCIL (2004) Microbiological procedures for the diagnosis of bovine 463 
udder infection and determination of milk quality. National Mastitis Council, Madison, WI 4th edition 464 
PERSSON, Y., NYMAN, A.-K. &  GRONLUND-ANDERSSON, U. (2011) Etiology and 465 
antimicrobial susceptibility of udder pathogens from cases of subclinical mastitis in dairy cows in 466 
Sweden. Acta Veterinaria Scandinavica 53, 36 467 
PITKÄLÄ, A., GINDONIS, V., WALLIN, H. &  HONKANEN-BUZALSKI, T. (2005) Interlaboratory 468 
Proficiency Testing as a Tool for Improving Performance in Laboratories Diagnosing Bovine Mastitis. 469 
Journal of Dairy Science 88, 553-559 470 
PITKALA, A., HAVERI, M., PYORALA, S., MYLLYS, V. &  HONKANEN-BUZALSKI, T. (2004) 471 
Bovine mastitis in Finland 2001--prevalence, distribution of bacteria, and antimicrobial resistance. 472 
Journal of Dairy Science 87, 2433-2441 473 
POL, M. &  RUEGG, P. L. (2007) Relationship between antimicrobial drug usage and antimicrobial 474 
susceptibility of gram-positive mastitis pathogens. Journal of Dairy Science 90, 262-273 475 
ROBERSON, J. R. (2012) Treatment of clinical mastitis. Vet Clin North Am Food Anim Pract 28, 271-476 
288 477 
ROYSTER, E., GODDEN, S., GOULART, D., DAHLKE, A., RAPNICKI, P. &  TIMMERMAN, J. 478 
(2014) Evaluation of the Minnesota Easy Culture System II Bi-Plate and Tri-Plate for identification of 479 
common mastitis pathogens in milk. J Dairy Sci 11, 2013-7748 480 
RUEGG, P. L. (2003) Investigation of mastitis problems on farms. Veterinary Clinics of North 481 
America Food Animal Practice 19, 47-73 482 
SOL, J., SAMPIMON, O. C., HARTMAN, E. &  BARKEMA, H. W. (2002) Effect of preculture 483 
freezing and incubation on bacteriological isolation from subclinical mastitis samples. Vet Microbiol 484 
85, 241-249 485 
SUOJALA, L., KAARTINEN, L. &  PYÖRÄLÄ, S. (2013) Treatment for bovine Escherichia coli 486 
mastitis – an evidence-based approach. Journal of Veterinary Pharmacology and Therapeutics 36, 521-487 
531 488 
TENHAGEN, B. A., KÖSTER, G., WALLMANN, J. &  HEUWIESER, W. (2006) Prevalence of 489 
Mastitis Pathogens and Their Resistance Against Antimicrobial Agents in Dairy Cows in Brandenburg, 490 
Germany. Journal of Dairy Science 89, 2542-2551 491 
UK-GOVERNMENT (2013) UK five year antimicrobial resistance strategy 2013 to 2018. Eds D. O. 492 
HEALTH, D. O. E. F. A. R. AFFAIRS. GOV.UK, Department of Health 493 
WALLACE, J. A., BOUCHARD, É., DESCÔTEAUX, L., MESSIER, S., DU TREMBLAY, D. &  494 
ROY, J.-P. (2011) Comparison of results for commercially available microbiological media plates with 495 
results for standard bacteriologic testing of bovine milk. American Journal of Veterinary Research 72, 496 
1622-1630 497 
WATTS, J. L. &  YANCEY, R. J. (1994) Identification of veterinary pathogens by use of commercial 498 
identification systems and new trends in antimicrobial susceptibility testing of veterinary pathogens. 499 
Clinical Microbiology Reviews 7, 346-356 500 
 501 
 502 
20 
 
Table 1 503 
Farm background information from five herds that contributed clinical and sub-clinical mastitis milk samples for evaluation of a culture-based mastitis 504 
pathogen detection test kit.  505 
 506 
Farm 
Number 
milking 
cows 
 
Average 
Days in Milka 
Average 
305d milk 
yielda 
3-month average 
bulk tank SCCa 
Incidence of clinical 
mastitisb 
Number 
clinical 
samples 
Number 
subclinical 
samples 
1 535 
 
173 
 
10730 156 44 cases 33 39 
2 545 
 
194 9020 237 52 cases 4 54 
3 70 
 
213 7985 290 72 cases 1 17 
4 218 
 
178 10392 320 64 cases 21 32 
5 89 
 
191 8603 315 75 cases 9 21 
        
a At date of enrolment into the study 507 
b The incidence of mastitis clinical was calculated for a 1-year period based on on-farm data records and expressed as cases/100 cows calving/year  508 
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Table 2 509 
Sensitivity (Se), specificity (Sp), positive predictive values (PPV) and negative predictive values (NPV) of a culture-based mastitis pathogen detection 510 
kit (‘VetoRapid’, Vétoquinol, Buckinghamshire, UK) for five common bacterial pathogens / pathogen groups, compared to standard laboratory culture. 511 
Pathogen Sample type Positive  Negative TP  FN  TN  FP  Se (95%CI) Sp (95%CI) PPV  NPV 
Escherichia coli  Clinical 15 53 10 5 49 4 67 (43-91) 92 (85-99) 70% 91% 
SC  4 159 1 3 158 1 25 (0-72) 99 (97-100) 34% 98% 
Total 19 212 11 8 207 5 58 (35-81) 98 (96-100) 72% 96% 
Coagulase-
negative 
Staphylococci  
Clinical 4 64 2 2 58 6 50 (1-99) 91 (84-98) 26% 97% 
SC 25 138 6 19 130 8 24 (7-41) 94 (90-98) 41% 88% 
Total 29 202 8 21 188 14 28 (12-44) 93 (89-97) 37% 90% 
Staphylococcus 
aureus  
Clinical 6 62 5 1 58 4 83 (53-100) 94 (88-100) 58% 98% 
SC 14 149 8 6 141 8 57 (32-82) 95 (91-99) 53% 96% 
Total 20 211 13 7 199 12 65 (44-86) 94 (91-97) 52% 96% 
Streptococcus 
uberis 
Clinical 13 55 12 1 52 3 92 (77-100) 95 (89-100) 81% 98% 
SC 6 157 4 2 142 15 67 (31-100) 90 (85-95) 22% 98% 
Total 19 212 16 3 194 18 84 (67-100) 92 (88-96) 48% 99% 
Enterococcus spp. Clinical 0 68 0 0 64 4 NA 94 (88-100) NA NA 
SC 12 151 2 10 140 11 17 (0-39) 93 (89-97) 15% 94% 
Total 12 219 2 10 204 15 17 (0-39) 93 (90-96) 11% 96% 
SC: sub-clinical; TP: true positive; FN: false negative; TN: true negative; FP: false positive; CI: confidence interval   512 
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Table 3 513 
Comparison of hypothetical selective treatment choices for 68 cases of clinical mastitis based on results from milk samples cultured by standard 514 
laboratory culture and by ‘VetoRapid’ (Vétoquinol, Buckinghamshire, UK), a culture-based mastitis pathogen detection test kit. Antimicrobial therapy 515 
was assigned only when a Gram-positive bacterium was isolated. 516 
Treatment outcome based on 
‘Vetorapid’ test kit  
Treatment outcome based on standard laboratory culture 
Antimicrobials No antimicrobials Total 
Antimicrobials 21 10** 31 
No antimicrobials 2* 35 37 
Total 23 45 68 
 517 
* plate result false negative for Streptococcus uberis (S. uberis) (1) and S. dysgalactiae (1). 518 
** plate result false positive for Enterococcus spp. (4), CNS (2), S. uberis (2), Staphylococcus aureus (S. aureus) and S. uberis (1), S. dysgalactiae (1).  519 
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Figures legends 520 
 521 
Figure 1. Two different Staphylococcus aureus isolates from mastitic milk samples 522 
cultured on a pathogen detection kit (‘VetoRapid’, Vétoquinol, Buckinghamshire, 523 
UK). Both isolates are growing in Sector 2, a modified Mannitol-Salt agar which 524 
supports the growth of organisms that tolerate high salt concentrations A: White 525 
colonies with yellow discoloration of the agar correctly identified as Staphylococcus 526 
aureus. B: White colonies with no discolouration of the agar incorrectly identified as 527 
coagulase-negative staphylococci. The pathogens came from stored mastitis isolates 528 
previously identified by the IDU laboratory as Staphylococcus aureus and were 529 
cultured in parallel using standard laboratory culture and the test kit. 530 
